brimonidine tartrate ophthalmic solution, 0.15%
Generic: brimonidine tartrate ophthalmic solution, 0.15%
Labeler: alembic pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
brimonidine tartrate ophthalmic solution, 0.15%
Generic Name
brimonidine tartrate ophthalmic solution, 0.15%
Labeler
alembic pharmaceuticals inc.
Dosage Form
SOLUTION/ DROPS
Routes
Active Ingredients
brimonidine tartrate 1.5 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
62332-661
Product ID
62332-661_66c10580-37cc-4061-ac10-1474ba0e60b8
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA215225
Listing Expiration
2026-12-31
Marketing Start
2023-03-29
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
62332661
Hyphenated Format
62332-661
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
brimonidine tartrate ophthalmic solution, 0.15% (source: ndc)
Generic Name
brimonidine tartrate ophthalmic solution, 0.15% (source: ndc)
Application Number
ANDA215225 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1.5 mg/mL
Packaging
- 1 BOTTLE in 1 CARTON (62332-661-05) / 5 mL in 1 BOTTLE
- 1 BOTTLE in 1 CARTON (62332-661-10) / 10 mL in 1 BOTTLE
- 1 BOTTLE in 1 CARTON (62332-661-15) / 15 mL in 1 BOTTLE
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["OPHTHALMIC"], "spl_id": "66c10580-37cc-4061-ac10-1474ba0e60b8", "openfda": {"unii": ["4S9CL2DY2H"], "rxcui": ["861208"], "spl_set_id": ["a52b2033-0333-4630-9b1f-e22918b0962c"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (62332-661-05) / 5 mL in 1 BOTTLE", "package_ndc": "62332-661-05", "marketing_start_date": "20230329"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (62332-661-10) / 10 mL in 1 BOTTLE", "package_ndc": "62332-661-10", "marketing_start_date": "20230329"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (62332-661-15) / 15 mL in 1 BOTTLE", "package_ndc": "62332-661-15", "marketing_start_date": "20230329"}], "brand_name": "Brimonidine Tartrate ophthalmic solution, 0.15%", "product_id": "62332-661_66c10580-37cc-4061-ac10-1474ba0e60b8", "dosage_form": "SOLUTION/ DROPS", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "62332-661", "generic_name": "Brimonidine Tartrate ophthalmic solution, 0.15%", "labeler_name": "Alembic Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Brimonidine Tartrate ophthalmic solution, 0.15%", "active_ingredients": [{"name": "BRIMONIDINE TARTRATE", "strength": "1.5 mg/mL"}], "application_number": "ANDA215225", "marketing_category": "ANDA", "marketing_start_date": "20230329", "listing_expiration_date": "20261231"}